Wikisage, the free encyclopedia of the second generation, is digital heritage

Amifampridine

From Wikisage
Jump to navigation Jump to search

Amifampridine phosphate was granted an Orphan Drug designation by the FDA for MG in September 2016, shortly after receiving a Refusal to File letter from the FDA for its submission for the treatment of congenital myasthenic syndromes and Lambert Eaton myasthenic syndrome (LEMS [1])[2]

ATC

Amifampridine
[3]

Links

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder Drug Trial Snapshot: Firdapse

References

References:

Q411707 op Wikidata  Interwiki via Wikidata